Alex A. Aimetti - Department of Chemical and Biological Engineering, University of Colorado

基本信息

浏览量：23

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 37 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Effect of Concomitant Antiseizure Medications on the Safety and Efficacy of Ganaxolone for the Treatment of Seizures Associated with CDKL5 Deficiency Disorder (CDD): Findings from the Phase 3 MARIGOLD Study (P8-1.006)

John Flatt,Sam Amin,Rajsekar Rajaraman,Alex Aimetti,Joseph Hulihan,Scott Perry

Neurology（2024）

引用0浏览0引用

Corrigendum to “phase 2, Placebo-Controlled Clinical Study of Oral Ganaxolone in PCDH19-clustering Epilepsy” [epilepsy Res. (2023) 191 107112]

Joseph Sullivan,Boudewijn Gunning,Muhammad Zafar, Renzo Guerrini,Jozef Gecz,Kristy L. Kolc, Yufan Zhao,Maciej Gasior,Alex A. Aimetti,Debopam Samanta

Epilepsy research（2024）

引用0浏览0WOS引用

Long-term Treatment with Ganaxolone for Seizures Associated with Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Two-year Open-Label Extension Follow-Up

Heather E. Olson,Sam Amin,Nadia Bahi-Buisson,Orrin Devinsky,Eric D. Marsh,Elia Pestana-Knight,Rajsekar R. Rajaraman,Alex A. Aimetti,Eva Rybak, Fanhui Kong,Ian Miller,Joseph Hulihan,Scott Demarest

EPILEPSIAno. 1 (2024): 37-45

引用0浏览0WOS引用

Analysis of Real-world Characteristics of Patients with CDKL5 Deficiency Disorder Enrolled for Ganaxolone Treatment (P6-1.010)

John Flatt,Alex Aimetti, Ian Miller

Neurology（2024）

引用0浏览0引用

Phase 2, Placebo-Controlled Clinical Study of Oral Ganaxolone in PCDH19-clustering Epilepsy

Joseph Sullivan,Boudewijn Gunning,Muhammad Zafar,Renzo Guerrini,Jozef Gecz,Kristy L. Kolc, Yufan Zhao,Maciej Gasior,Alex A. Aimetti,Debopam Samanta

Epilepsy research（2023）

引用3浏览0WOS引用

Phase 2 Open-label Clinical Study Evaluating Oral Ganaxolone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex (P12-8.002)

Mary Kay Koenig,Rajeshwari Mahalingam, Jurriaan M. Peters,Brenda E. Porter,Rajsekar R. Rajaraman,Muhammad Zafar,Alex A. Aimetti, Ian Miller,Joseph Hulihan,Darcy A. Krueger

Neurologyno. 18_supplement (2022)

引用0浏览0引用

Intravenous Ganaxolone for the Treatment of Refractory Status Epilepticus: Results from an Open‐label, Dose‐finding, Phase 2 Trial

Henrikas Vaitkevicius,R. Eugene Ramsay,Christa B. Swisher,Aatif M. Husain,Alex Aimetti,Maciej Gasior

Epilepsia（2022）

引用1浏览0WOS引用

Safety and Efficacy of Ganaxolone in Patients with CDKL5 Deficiency Disorder: Results from the Double-Blind Phase of a Randomised, Placebo-Controlled, Phase 3 Trial

Elia M. Pestana Knight,Sam Amin,Nadia Bahi-Buisson,Tim A. Benke,J. Helen Cross,Scott T. Demarest,Heather E. Olson,Nicola Specchio,Thomas R. Fleming,Alex A. Aimetti,Maciej Gasior,Orrin Devinsky

LANCET NEUROLOGYno. 5 (2022): 417-427

引用46浏览0WOS引用

Extended Duration Safety and Efficacy of Adjunctive Ganaxolone Treatment in Patients with CDKL5 Deficiency Disorder: 8-Month Minimum Open-Label Extension Follow-up (S13.005)

Heather E. Olson,Ahsan N. Moosa,Eva Rybak,Alex A. Aimetti, Joseph Hulihan,Elia Pestana Knight

Neurologyno. 18_supplement (2022)

引用0浏览0引用

Association Between Treatment Progression, Disease Refractoriness, And Burden Of Illness Among Hospitalized Patients With Status Epilepticus

Elan L Guterman,John P Betjemann,Alex Aimetti,Justin W Li,Zheng Wang,David Yin,Joseph Hulihan,Thomas Lyons,Gavin Miyasato,Adam Strzelczyk

JAMA NEUROLOGY（2021）

引用31浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn